Tagged: intralytix

$17.5 million equity placement completed by Intralytix

XDATA – June 12th 2017
Intralytix disclosed raising $17.5 million as part of a non-brokered equity private placement. One investor acquired the securities almost two weeks ago. The equity offering’s estimated net proceeds amount to $15.62 million excluding $1.88 million earmarked for the payment of officers’ salaries. No offering was previously initiated by the company under a registration exemption with the SEC.
The company is a biotechnology specialized in bacteriophage-based products used to control bacterial pathogens in environmental, food processing, and medical settings.
The company is headquartered in Baltimore MD. Intralytix elected to keep its revenues undisclosed.
The executive team includes Alexander Sulakvelidze, John J Woloszyn and Mel Ruzicka.
The board of directors includes Gary Pasterneck and Patrick Hervy.
Offering recap
Status: Completed
Company: Intralytix
Industry: Other
Amount offered: $17.5 million
Amount placed: $17.5 million
SEC filing: Source
First sale: 05-31-2017
Data as of: 06-12-2017